G Wolfram

919 total citations
47 papers, 704 citations indexed

About

G Wolfram is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology and Surgery. According to data from OpenAlex, G Wolfram has authored 47 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Physiology and 9 papers in Surgery. Recurrent topics in G Wolfram's work include Lipoproteins and Cardiovascular Health (4 papers), Diet and metabolism studies (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). G Wolfram is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Diet and metabolism studies (4 papers) and Growth Hormone and Insulin-like Growth Factors (4 papers). G Wolfram collaborates with scholars based in Germany, United States and Belgium. G Wolfram's co-authors include O. Adam, Michael D. Smith, Christine R. West, Mark T. Brown, N. Zöllner, Egilius L.H. Spierings, R. Gerzer, Isabelle Davignon, Eugen Feist and Andra Bălănescu and has published in prestigious journals such as American Journal of Clinical Nutrition, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

G Wolfram

44 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Wolfram Germany 15 263 121 110 110 109 47 704
Deniz Erbaş Türkiye 16 246 0.9× 63 0.5× 62 0.6× 59 0.5× 25 0.2× 50 794
Elisabeth Svanberg Sweden 20 575 2.2× 67 0.6× 36 0.3× 195 1.8× 81 0.7× 38 1.2k
Keiji Yoshioka Japan 20 314 1.2× 132 1.1× 19 0.2× 138 1.3× 66 0.6× 64 830
J Koška Slovakia 12 208 0.8× 65 0.5× 32 0.3× 199 1.8× 57 0.5× 31 700
Michael T. Pedrini Austria 13 308 1.2× 109 0.9× 32 0.3× 307 2.8× 46 0.4× 22 1.1k
Gábor Sütő Hungary 15 149 0.6× 246 2.0× 45 0.4× 136 1.2× 45 0.4× 64 697
Francine Einstein United States 15 529 2.0× 118 1.0× 164 1.5× 181 1.6× 41 0.4× 30 1.2k
H.K. Nielsen Denmark 17 257 1.0× 83 0.7× 31 0.3× 117 1.1× 21 0.2× 31 800
Hyeong Kyu Park South Korea 15 584 2.2× 112 0.9× 41 0.4× 222 2.0× 90 0.8× 50 1.5k
V. Martina Italy 13 163 0.6× 79 0.7× 23 0.2× 173 1.6× 23 0.2× 35 551

Countries citing papers authored by G Wolfram

Since Specialization
Citations

This map shows the geographic impact of G Wolfram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Wolfram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Wolfram more than expected).

Fields of papers citing papers by G Wolfram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Wolfram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Wolfram. The network helps show where G Wolfram may publish in the future.

Co-authorship network of co-authors of G Wolfram

This figure shows the co-authorship network connecting the top 25 collaborators of G Wolfram. A scholar is included among the top collaborators of G Wolfram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Wolfram. G Wolfram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sopata, Maciej, Nathaniel P. Katz, William Carey, et al.. (2015). Efficacy and safety of tanezumab in the treatment of pain from bone metastases. Pain. 156(9). 1703–1713. 60 indexed citations
3.
Wolfram, G, et al.. (2014). Exporting Culture. DIAL (Catholic University of Leuven). 1 indexed citations
5.
Spierings, Egilius L.H., et al.. (2013). A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee. Pain. 154(9). 1603–1612. 103 indexed citations
6.
Weiss, M.D. Gregory M., et al.. (2009). Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: One-year follow-up with improved metabolic control. Experimental and Clinical Endocrinology & Diabetes. 107(5). 306–312. 3 indexed citations
7.
Adam, O., et al.. (2008). Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans. Prostaglandins Leukotrienes and Essential Fatty Acids. 79(3-5). 177–181. 40 indexed citations
8.
9.
Baisch, F., Luis Beck, G. Blomqvist, et al.. (2000). Cardiovascular response to lower body negative pressure stimulation before, during, and after space flight. European Journal of Clinical Investigation. 30(12). 1055–1065. 32 indexed citations
10.
Zwißler, Bernhard, G. Kemming, Olivia M. Merkel, et al.. (1999). Response to inhaled nitric oxide (NO) is not associated with changes of plasma cGMP levels in patients with acute lung injury.. PubMed. 4(11). 463–7. 8 indexed citations
11.
Kaufmann, S., G Wolfram, François Delange, & W. A. Rambeck. (1998). Iodine supplementation of laying hen feed: A supplementary measure to eliminate iodine deficiency in humans?. Zeitschrift für Ernährungswissenschaft. 37(3). 288–293. 25 indexed citations
12.
Linseisen, Jakob, et al.. (1998). Sucrose intake in Germany (Saccharosezufuhr in Deutschland). Zeitschrift für Ernährungswissenschaft. 37(4). 303–314. 21 indexed citations
13.
Wolfram, G, et al.. (1996). Assessment of dry weight in haemodialysis patients by the volume markers ANP and cGMP. Nephrology Dialysis Transplantation. 11(supp2). 28–30. 21 indexed citations
14.
Wolfram, G. (1995). [Diet in hyperlipidemia, hypertension and gout].. PubMed. 36(11). 1070–6. 1 indexed citations
15.
Schuster, H., et al.. (1994). Identification of defective binding of low density lipoprotein by the U937 proliferation assay in German patients with familial defective apolipoprotein B‐100. European Journal of Clinical Investigation. 24(1). 36–41. 14 indexed citations
16.
Ivanova, Krassimira, et al.. (1994). Soluble Guanylyl Cyclase and Platelet Functiona. Annals of the New York Academy of Sciences. 714(1). 151–157. 42 indexed citations
17.
Huber, Rudolf M., Jochen Schopohl, Marco Losa, et al.. (1991). Growth-hormone releasing hormone in a bronchial carcinoid. Cancer. 67(10). 2538–2542. 10 indexed citations
18.
Schopohl, Jochen, et al.. (1991). Plasma growth hormone (GH)‐releasing hormone levels in patients with lung carcinoma. Clinical Endocrinology. 34(6). 463–467. 12 indexed citations
19.
Losa, Marco, et al.. (1990). Presence of Growth Hormone-Releasing Hormone-Like Immunoreactivity in Human Tumors: Characterization of Immunological and Biological Properties*. The Journal of Clinical Endocrinology & Metabolism. 70(1). 62–68. 22 indexed citations
20.
Adam, O., G Wolfram, & N. Zöllner. (1980). Platelet fatty acids and prostaglandin turnover during defined linoleic acid intake with formula diets.. PubMed. 8(1). 85–9. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026